Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour necrosis factor in vivo.

Chuncharunee S, Carter CD, Studtmann KE, Caro J, Coffey RJ, Dessypris EN
Br J Haematol. 1993 84 (3): 374-80

PMID: 8217788 · DOI:10.1111/j.1365-2141.1993.tb03089.x

MeSH Terms (11)

Animals Blood Cell Count Erythropoiesis Erythropoietin Hematopoietic Stem Cells Mice Mice, Inbred BALB C Recombinant Proteins Spleen Transforming Growth Factor beta Tumor Necrosis Factor-alpha

Connections (2)

This publication is referenced by other Labnodes entities: